Aurobindo Pharma | The company had reported 80 percent rise in consolidated net profit to Rs 909 crore in the Jan-March quarter of FY24 from Rs 508 crore in the same period a year ago.
USFDA classifies Aurobindo Pharma arm Eugia s mfg Unit III as official action indicated moneycontrol.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from moneycontrol.com Daily Mail and Mail on Sunday newspapers.
After Spice, Indian Medicines Being Recalled From US Over Manufacturing Issues - Trak in - Indian Business of Tech, Mobile & Startups trak.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from trak.in Daily Mail and Mail on Sunday newspapers.